跳至主要内容
临床试验/CTRI/2018/04/013453
CTRI/2018/04/013453已完成4 期

Efficacy, Safety and Cost effectiveness of Telmisartan and Cilnidipine in Hypertensive Patients with coronary artery disease in a tertiary care hospital.

SRM0 个研究点目标入组 126 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
SRM
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Male and female patients 18-80 years of age.
  • 2.Known hypertensive patients with coronary artery
  • 3.Range of blood pressure in >140/90mmHg
  • 4.Hypertensive patients with co morbidity conditions like Diabetes mellitus, Dyslipidemia

排除标准

  • 1.Age below 18 years and above 80 years
  • 2.Pregnant and lactating women.
  • 3.Patients with hepatic impairment.
  • 4.Patients with acute illness or blood pressure >180mmHg systolic or >120mmHg diastolic
  • 5.Known hypersensitivity to telmisartan/cilnidipine.

研究者

发起方
SRM

相似试验